10-Q Filing

ALIGNMENT HEALTHCARE, INC. CIK: 1832466 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0000950170-21-003106`
Period End Date	20210930
Filing Date	20211104
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	alhc-20210930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 64 Cash Flow Statement 80 Stockholders Equity 42

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$74.00K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`Cash`	$500.49M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	0.00	shares	Point-in-time
Cash	`Cash`	$207.31M	USD	Point-in-time
Accounts receivable (less allowance for credit losses of $74 at September 30, 2021 and $0 at December 31, 2020, respectively)	`AccountsReceivableNetCurrent`	$40.14M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable (less allowance for credit losses of $74 at September 30, 2021 and $0 at December 31, 2020, respectively)	`AccountsReceivableNetCurrent`	$47.67M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$29.24M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$17.23M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$577.39M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$264.68M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$27.14M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$31.50M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	164.06M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$8.27M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	164.06M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$9.89M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	187.25M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	164.06M	shares	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$35.21M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$34.65M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	187.25M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$2.15M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.54M	USD	Point-in-time
Total assets	`Assets`	$338.50M	USD	Point-in-time
Total assets	`Assets`	$656.93M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$112.61M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$128.78M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$15.68M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$16.56M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$25.17M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$29.81M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$175.14M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$153.45M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$148.97M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$144.17M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$10.27M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$7.74M	USD	Point-in-time
Total liabilities	`Liabilities`	$307.89M	USD	Point-in-time
Total liabilities	`Liabilities`	$331.85M	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 and 0 shares authorized as of September 30, 2021 and December 31, 2020 respectively; no shares issued and outstanding as of September 30, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 and 0 shares authorized as of September 30, 2021 and December 31, 2020 respectively; no shares issued and outstanding as of September 30, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 and 164,063,787 shares authorized as of September 30, 2021 and December 31, 2020 respectively; 187,250,836 and 164,063,787 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$164.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 and 164,063,787 shares authorized as of September 30, 2021 and December 31, 2020 respectively; 187,250,836 and 164,063,787 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$188.00K	USD	Point-in-time
Additional Paid in Capital	`AdditionalPaidInCapital`	$851.89M	USD	Point-in-time
Additional Paid in Capital	`AdditionalPaidInCapital`	$410.02M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-379.57M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-527.02M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$325.06M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$30.61M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$15.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	-	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.68M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$340.38M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$78.71M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$50.86M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$325.07M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$656.93M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$338.50M	USD	Point-in-time

Income Statement 64 line items

Line Item	Tag	Value	Unit	Period
Earned premiums	`PremiumsEarnedNet`	$869.01M	USD	3 Qtrs
Earned premiums	`PremiumsEarnedNet`	$245.49M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$293.27M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$713.71M	USD	3 Qtrs
Other	`RevenueNotFromContractWithCustomer`	$3.10M	USD	3 Qtrs
Other	`RevenueNotFromContractWithCustomer`	$485.00K	USD	3 Qtrs
Other	`RevenueNotFromContractWithCustomer`	$191.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$2.38M	USD	1 Quarter
Total revenues	`Revenues`	$869.50M	USD	3 Qtrs
Total revenues	`Revenues`	$716.81M	USD	3 Qtrs
Total revenues	`Revenues`	$247.87M	USD	1 Quarter
Total revenues	`Revenues`	$293.47M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$190.08M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$253.99M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$577.98M	USD	3 Qtrs
Medical expenses	`MedicalExpenses`	$779.47M	USD	3 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$105.28M	USD	3 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$212.91M	USD	3 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$38.79M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$76.85M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$11.02M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.93M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$11.72M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.08M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$1.00B	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$334.92M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$232.81M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$694.28M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-41.45M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$22.53M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-134.61M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$15.06M	USD	1 Quarter
Interest expense	`InterestExpense`	$12.99M	USD	3 Qtrs
Interest expense	`InterestExpense`	$4.41M	USD	1 Quarter
Interest expense	`InterestExpense`	$4.27M	USD	1 Quarter
Interest expense	`InterestExpense`	$12.62M	USD	3 Qtrs
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$-57.00K	USD	1 Quarter
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$770.00K	USD	3 Qtrs
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$-145.00K	USD	3 Qtrs
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$-48.00K	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-12.85M	USD	3 Qtrs
Total other expenses	`OtherNonoperatingIncomeExpense`	$-4.21M	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-13.39M	USD	3 Qtrs
Total other expenses	`OtherNonoperatingIncomeExpense`	$-4.37M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$10.85M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-45.82M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$9.14M	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-147.45M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-45.82M	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$10.85M	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$9.14M	USD	3 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-147.45M	USD	3 Qtrs
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	177.83M	shares	1 Quarter
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	148.75M	shares	3 Qtrs
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	152.26M	shares	1 Quarter
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	169.79M	shares	3 Qtrs
Net income (loss) per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$0.06	USD	3 Qtrs
Net income (loss) per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.87	USD	3 Qtrs
Net income (loss) per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.26	USD	1 Quarter
Net income (loss) per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$0.07	USD	1 Quarter

Cash Flow Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-147.45M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$9.14M	USD	3 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$54.00K	USD	3 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$74.00K	USD	3 Qtrs
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$19.00K	USD	1 Quarter
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$28.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$11.88M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$11.30M	USD	3 Qtrs
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCosts`	$1.63M	USD	3 Qtrs
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCosts`	$1.68M	USD	3 Qtrs
Payment-in-kind interest	`PaidInKindInterest`	$3.12M	USD	3 Qtrs
Payment-in-kind interest	`PaidInKindInterest`	$2.99M	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-990.00K	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	3 Qtrs
Equity-based compensation and common stock payments	`ShareBasedCompensationAndCommonStockPayments`	$980.00K	USD	3 Qtrs
Equity-based compensation and common stock payments	`ShareBasedCompensationAndCommonStockPayments`	$81.79M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseCost`	$1.76M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseCost`	$2.00M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$6.73M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$972.00K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$10.25M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$11.83M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-8.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-35.00K	USD	3 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$-2.12M	USD	3 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$15.40M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-3.50M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-443.00K	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$4.64M	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$7.24M	USD	3 Qtrs
Lease liabilities	`OperatingLeasePayments`	$2.36M	USD	3 Qtrs
Lease liabilities	`OperatingLeasePayments`	$2.78M	USD	3 Qtrs
Noncurrent liabilities	`IncreaseDecreaseInNoncurrentLiabilities`	-	USD	3 Qtrs
Noncurrent liabilities	`IncreaseDecreaseInNoncurrentLiabilities`	$-3.94M	USD	3 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$17.71M	USD	3 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-48.64M	USD	3 Qtrs
Asset acquisition, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	$1.41M	USD	3 Qtrs
Asset acquisition, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	-	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$1.32M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$2.48M	USD	3 Qtrs
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$1.43M	USD	3 Qtrs
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$575.00K	USD	3 Qtrs
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-10.98M	USD	3 Qtrs
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-15.41M	USD	3 Qtrs
Proceeds from the sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	3 Qtrs
Proceeds from the sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$100.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-11.63M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-17.86M	USD	3 Qtrs
Purchase of noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	$15.00K	USD	3 Qtrs
Purchase of noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	3 Qtrs
Equity repurchase	`PaymentsForRepurchaseOfEquity`	$1.47M	USD	3 Qtrs
Equity repurchase	`PaymentsForRepurchaseOfEquity`	$1.36M	USD	3 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$390.60M	USD	3 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$135.00M	USD	3 Qtrs
Common stock issuance costs	`PaymentsOfStockIssuanceCosts`	$29.01M	USD	3 Qtrs
Common stock issuance costs	`PaymentsOfStockIssuanceCosts`	$3.37M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$130.27M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$360.13M	USD	3 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$136.34M	USD	3 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$293.62M	USD	3 Qtrs
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$222.83M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$501.44M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$86.48M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$222.83M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$501.44M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$86.48M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$8.00M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$8.19M	USD	3 Qtrs
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$438.00K	USD	3 Qtrs
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$43.00K	USD	3 Qtrs
Cash	`CashAndCashEquivalentsAtCarryingValue`	$222.33M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$500.49M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$950.00K	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$222.83M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$501.44M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$86.48M	USD	Point-in-time

Stockholders Equity 42 line items

Line Item	Tag	Value	Unit	Period
Common stock issuance costs	`StockIssuedDuringPeriodIssuanceCosts`	-	USD	1 Quarter
Common stock issuance costs	`StockIssuedDuringPeriodIssuanceCosts`	-	USD	1 Quarter
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.68M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$340.38M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$78.71M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$50.86M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$325.07M	USD	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	164.06M	shares	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	187.25M	shares	Point-in-time
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-45.82M	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$10.85M	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$9.14M	USD	3 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-147.45M	USD	3 Qtrs
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$15.00K	USD	3 Qtrs
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	1 Quarter
Common stock issuance costs	`StockIssuedDuringPeriodIssuanceCosts`	-	USD	1 Quarter
Common stock issuance costs	`StockIssuedDuringPeriodIssuanceCosts`	-	USD	1 Quarter
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$361.59M	USD	3 Qtrs
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$131.63M	USD	3 Qtrs
Issuance of common stock to third-party business partners	`StockIssuedDuringPeriodValueToTheThirdPartyBusinessProviders`	$6.48M	USD	3 Qtrs
Issuance of common stock to third-party business partners	`StockIssuedDuringPeriodValueToTheThirdPartyBusinessProviders`	-	USD	1 Quarter
Issuance of common stock to stock appreication rights holders	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$11.51M	USD	3 Qtrs
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	1 Quarter
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	3 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$304.00K	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$30.51M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$980.00K	USD	3 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$63.80M	USD	3 Qtrs
Equity repurchase	`StockRepurchasedDuringPeriodValue`	$1.36M	USD	3 Qtrs
Equity repurchase	`StockRepurchasedDuringPeriodValue`	$1.47M	USD	3 Qtrs
Equity repurchase	`StockRepurchasedDuringPeriodValue`	$338.00K	USD	1 Quarter
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.68M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$340.38M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$78.71M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$50.86M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$325.07M	USD	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	164.06M	shares	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	187.25M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.